Bioventus (BVS) Interest Expenses (2020 - 2026)
Bioventus' (BVS) quarterly Interest Expenses came in at $938000.0 in Q1 2026, up 5.16% YoY from $892000.0 in Q1 2025, and down 96.15% on a QoQ basis from $24.4 million in Q4 2025.
Bioventus (BVS) Interest Expenses (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Interest Expenses data on file, last reported at $938000.0 in Q1 2026.
- Quarterly Interest Expenses rose 5.16% year-over-year to $938000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.2 million (down 7.09% YoY) and the FY2025 annual result came in at $47.6 million, down 8.28% from the prior year.
- Interest Expenses retreated to $938000.0 in Q1 2026, from $24.4 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $35.0 million in Q4 2024 to a low of $203000.0 in Q4 2022.
- A 5-year average of $14.2 million and a median of $14.5 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 98.73% — and 2023, when it soared 9805.91%.
- Tracing BVS's Interest Expenses over 5 years: stood at $14.5 million in 2022, then soared by 98.2% to $28.8 million in 2023, then gained by 21.72% to $35.0 million in 2024, then plunged by 30.5% to $24.4 million in 2025, then plunged by 96.15% to $938000.0 in 2026.
- The last three Interest Expenses figures came in at $938000.0 (Q1 2026), $24.4 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Bioventus | 976.64 Mn | 947.18 Mn | 105.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 22.43 Mn |
| Jun 27, 2026 | 22.43 Mn |
| Mar 28, 2026 | 938,000.00 |
| Mar 28, 2026 | 938,000.00 |
| Dec 31, 2025 | 24.36 Mn |
| Dec 31, 2025 | 24.36 Mn |
| Sep 27, 2025 | 5.93 Mn |
| Sep 27, 2025 | 5.93 Mn |
| Jun 28, 2025 | 6.44 Mn |
| Jun 28, 2025 | 6.44 Mn |
| Mar 29, 2025 | 892,000.00 |
| Mar 29, 2025 | 892,000.00 |
| Dec 31, 2024 | 35.05 Mn |
| Dec 31, 2024 | 35.05 Mn |
| Sep 28, 2024 | 31.01 Mn |
| Sep 28, 2024 | 31.01 Mn |
| Jun 29, 2024 | 31.01 Mn |
| Jun 29, 2024 | 31.01 Mn |
| Mar 30, 2024 | 1.18 Mn |
| Mar 30, 2024 | 1.18 Mn |